Skip to main navigation Skip to search Skip to main content

Aptamers for Targeted Therapy

  • Beijing Institute of Technology

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

This chapter introduces the aptamers for targeted therapy. Aptamers show promising efficacy and safety in four types of clinical studies of ophthalmopathy, blood coagulation, inflammation, and cancer, and there are increasing numbers of evidences to prove the clinical application potential of aptamers. To date, more than a dozen aptamers have entered clinical trials as therapeutic agents for targeted therapy. This chapter introduces their pharmacological development and optimization processes and reviews potential treatment of diseases.

Original languageEnglish
Title of host publicationAptamers for Medical Applications
Subtitle of host publicationFrom Diagnosis to Therapeutics
PublisherSpringer Singapore
Pages129-178
Number of pages50
ISBN (Electronic)9789813348387
ISBN (Print)9789813348370
DOIs
Publication statusPublished - 1 Jan 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Aptamers
  • Cancer
  • Coagulation
  • Inflammation
  • Oculopathy
  • Target therapy

Fingerprint

Dive into the research topics of 'Aptamers for Targeted Therapy'. Together they form a unique fingerprint.

Cite this